209 related articles for article (PubMed ID: 27477385)
1. Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing Antibodies.
Davenport TM; Gorman J; Joyce MG; Zhou T; Soto C; Guttman M; Moquin S; Yang Y; Zhang B; Doria-Rose NA; Hu SL; Mascola JR; Kwong PD; Lee KK
Structure; 2016 Aug; 24(8):1346-1357. PubMed ID: 27477385
[TBL] [Abstract][Full Text] [Related]
2. Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies.
Hwang JK; Wang C; Du Z; Meyers RM; Kepler TB; Neuberg D; Kwong PD; Mascola JR; Joyce MG; Bonsignori M; Haynes BF; Yeap LS; Alt FW
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):8614-8619. PubMed ID: 28747530
[TBL] [Abstract][Full Text] [Related]
3. Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition.
Chuang GY; Zhou J; Acharya P; Rawi R; Shen CH; Sheng Z; Zhang B; Zhou T; Bailer RT; Dandey VP; Doria-Rose NA; Louder MK; McKee K; Mascola JR; Shapiro L; Kwong PD
Structure; 2019 Jan; 27(1):196-206.e6. PubMed ID: 30471922
[TBL] [Abstract][Full Text] [Related]
4. All eyes on the next generation of HIV vaccines: strategies for inducing a broadly neutralizing antibody response.
Ahlers JD
Discov Med; 2014 Apr; 17(94):187-99. PubMed ID: 24759623
[TBL] [Abstract][Full Text] [Related]
5. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function.
Tsuji I; Vang F; Dominguez D; Karwal L; Sanjali A; Livengood JA; Davidson E; Fouch ME; Doranz BJ; Das SC; Dean HJ
J Virol; 2022 Jun; 96(11):e0007122. PubMed ID: 35575481
[TBL] [Abstract][Full Text] [Related]
6. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
McGuire AT; Glenn JA; Lippy A; Stamatatos L
J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
[TBL] [Abstract][Full Text] [Related]
7. Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine.
Zhou T; Xu K
Adv Exp Med Biol; 2018; 1075():73-95. PubMed ID: 30030790
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans.
Wu NR; Nicely NI; Lee EM; Reed RK; Watts BE; Cai F; Walkowicz WE; Aussedat B; Jones JA; Eaton A; Trama AM; Alam SM; Montefiori DC; Haynes BF; Saunders KO
PLoS Pathog; 2019 Dec; 15(12):e1008165. PubMed ID: 31841553
[TBL] [Abstract][Full Text] [Related]
9. Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies.
Henderson R; Watts BE; Ergin HN; Anasti K; Parks R; Xia SM; Trama A; Liao HX; Saunders KO; Bonsignori M; Wiehe K; Haynes BF; Alam SM
Nat Commun; 2019 Feb; 10(1):654. PubMed ID: 30737386
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant.
Simonich CA; Williams KL; Verkerke HP; Williams JA; Nduati R; Lee KK; Overbaugh J
Cell; 2016 Jun; 166(1):77-87. PubMed ID: 27345369
[TBL] [Abstract][Full Text] [Related]
11. Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans.
Julien JP; Sok D; Khayat R; Lee JH; Doores KJ; Walker LM; Ramos A; Diwanji DC; Pejchal R; Cupo A; Katpally U; Depetris RS; Stanfield RL; McBride R; Marozsan AJ; Paulson JC; Sanders RW; Moore JP; Burton DR; Poignard P; Ward AB; Wilson IA
PLoS Pathog; 2013; 9(5):e1003342. PubMed ID: 23658524
[TBL] [Abstract][Full Text] [Related]
12. Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding.
Julien JP; Huarte N; Maeso R; Taneva SG; Cunningham A; Nieva JL; Pai EF
J Virol; 2010 May; 84(9):4136-47. PubMed ID: 20147404
[TBL] [Abstract][Full Text] [Related]
13. Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth.
Chen X; Zhou T; Schmidt SD; Duan H; Cheng C; Chuang GY; Gu Y; Louder MK; Lin BC; Shen CH; Sheng Z; Zheng MX; Doria-Rose NA; Joyce MG; Shapiro L; Tian M; Alt FW; Kwong PD; Mascola JR
Immunity; 2021 Feb; 54(2):324-339.e8. PubMed ID: 33453152
[TBL] [Abstract][Full Text] [Related]
14. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
Doria-Rose NA; Schramm CA; Gorman J; Moore PL; Bhiman JN; DeKosky BJ; Ernandes MJ; Georgiev IS; Kim HJ; Pancera M; Staupe RP; Altae-Tran HR; Bailer RT; Crooks ET; Cupo A; Druz A; Garrett NJ; Hoi KH; Kong R; Louder MK; Longo NS; McKee K; Nonyane M; O'Dell S; Roark RS; Rudicell RS; Schmidt SD; Sheward DJ; Soto C; Wibmer CK; Yang Y; Zhang Z; ; Mullikin JC; Binley JM; Sanders RW; Wilson IA; Moore JP; Ward AB; Georgiou G; Williamson C; Abdool Karim SS; Morris L; Kwong PD; Shapiro L; Mascola JR
Nature; 2014 May; 509(7498):55-62. PubMed ID: 24590074
[TBL] [Abstract][Full Text] [Related]
15. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies.
Fetzer I; Davis-Gardner ME; Gardner MR; Alfant B; Weber JA; Prasad NR; Zhou AS; Farzan M
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541842
[TBL] [Abstract][Full Text] [Related]
16. The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies.
Sok D; Laserson U; Laserson J; Liu Y; Vigneault F; Julien JP; Briney B; Ramos A; Saye KF; Le K; Mahan A; Wang S; Kardar M; Yaari G; Walker LM; Simen BB; St John EP; Chan-Hui PY; Swiderek K; Kleinstein SH; Alter G; Seaman MS; Chakraborty AK; Koller D; Wilson IA; Church GM; Burton DR; Poignard P
PLoS Pathog; 2013; 9(11):e1003754. PubMed ID: 24278016
[TBL] [Abstract][Full Text] [Related]
17. A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure.
Lee JH; Andrabi R; Su CY; Yasmeen A; Julien JP; Kong L; Wu NC; McBride R; Sok D; Pauthner M; Cottrell CA; Nieusma T; Blattner C; Paulson JC; Klasse PJ; Wilson IA; Burton DR; Ward AB
Immunity; 2017 Apr; 46(4):690-702. PubMed ID: 28423342
[TBL] [Abstract][Full Text] [Related]
18. Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice.
Kosztyu P; Kuchar M; Cerny J; Barkocziova L; Maly M; Petrokova H; Czernekova L; Liskova V; Raskova Kafkova L; Knotigova P; Masek J; Turanek J; Maly P; Raska M
EBioMedicine; 2019 Sep; 47():247-256. PubMed ID: 31544770
[TBL] [Abstract][Full Text] [Related]
19. HIV Broadly Neutralizing Antibodies: VRC01 and Beyond.
Wu X
Adv Exp Med Biol; 2018; 1075():53-72. PubMed ID: 30030789
[TBL] [Abstract][Full Text] [Related]
20. Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies.
Wu X; Kong XP
Curr Opin Immunol; 2016 Oct; 42():56-64. PubMed ID: 27289425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
